Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction

Background: “Frailty” is associated with poor prognosis in ST-elevated myocardial infarction (STEMI). However, there is little data regarding the impact of the Canadian Study of Health and Aging Clinical Frailty Scale (CFS), a simple and semiquantitative tool for assessing frailty, on mid-term morta...

Full description

Bibliographic Details
Main Authors: Naoki Yoshioka, Kensuke Takagi, Yasuhiro Morita, Ruka Yoshida, Hiroaki Nagai, Yasunori Kanzaki, Koichi Furui, Ryota Yamauchi, Shotaro Komeyama, Hiroki Sugiyama, Hideyuki Tsuboi, Itsuro Morishima
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:International Journal of Cardiology: Heart & Vasculature
Online Access:http://www.sciencedirect.com/science/article/pii/S235290671930003X
id doaj-ab9819785a454567845c28ce6b837d64
record_format Article
spelling doaj-ab9819785a454567845c28ce6b837d642020-11-24T23:34:47ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672019-03-0122192198Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarctionNaoki Yoshioka0Kensuke Takagi1Yasuhiro Morita2Ruka Yoshida3Hiroaki Nagai4Yasunori Kanzaki5Koichi Furui6Ryota Yamauchi7Shotaro Komeyama8Hiroki Sugiyama9Hideyuki Tsuboi10Itsuro Morishima11Department of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanCorresponding author at: Ogaki Municipal Hospital, 4-86 Minaminokawa-cho, Ogaki, Gifu, Japan.; Department of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanBackground: “Frailty” is associated with poor prognosis in ST-elevated myocardial infarction (STEMI). However, there is little data regarding the impact of the Canadian Study of Health and Aging Clinical Frailty Scale (CFS), a simple and semiquantitative tool for assessing frailty, on mid-term mortality in STEMI patients. Methods: A total of 354 consecutive STEMI patients (mean age 69.8 ± 12.4 years; male 76.6%) who underwent percutaneous intervention between July 2014 and March 2017 were retrospectively reviewed. The study endpoint was mid-term mortality according to the CFS classification. Furthermore, in order to clarify the impact of CFS upon admission on mid-term mortality, the independent predictors of all-cause death were evaluated. Results: Patients were categorized into three groups (CFS 1–3, n = 281; CFS 4–5, n = 62; and CFS 6–7, n = 11). During the study period (median 474 days), all-cause death was observed in 39 patients. After multivariate Cox regression analysis, higher CFS (adjusted hazard ratio [HR] 2.34, 95% confidence interval [CI] 1.43–3.85, p < 0.001), higher Killip score (adjusted HR 2.46, 95%CI 1.30–5.78, p = 0.002), and lower serum albumin level (adjusted HR 4.29, 95%CI 2.16–8.51, p < 0.001) were significantly associated with an increased risk of all-cause death. Conclusion: In conclusion, severe frailty was associated with mid-term mortality in STEMI patients who underwent PCI. Keywords: Coronary heart disease, ST-elevated myocardial infarction, Frail, Prognosishttp://www.sciencedirect.com/science/article/pii/S235290671930003X
collection DOAJ
language English
format Article
sources DOAJ
author Naoki Yoshioka
Kensuke Takagi
Yasuhiro Morita
Ruka Yoshida
Hiroaki Nagai
Yasunori Kanzaki
Koichi Furui
Ryota Yamauchi
Shotaro Komeyama
Hiroki Sugiyama
Hideyuki Tsuboi
Itsuro Morishima
spellingShingle Naoki Yoshioka
Kensuke Takagi
Yasuhiro Morita
Ruka Yoshida
Hiroaki Nagai
Yasunori Kanzaki
Koichi Furui
Ryota Yamauchi
Shotaro Komeyama
Hiroki Sugiyama
Hideyuki Tsuboi
Itsuro Morishima
Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction
International Journal of Cardiology: Heart & Vasculature
author_facet Naoki Yoshioka
Kensuke Takagi
Yasuhiro Morita
Ruka Yoshida
Hiroaki Nagai
Yasunori Kanzaki
Koichi Furui
Ryota Yamauchi
Shotaro Komeyama
Hiroki Sugiyama
Hideyuki Tsuboi
Itsuro Morishima
author_sort Naoki Yoshioka
title Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction
title_short Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction
title_full Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction
title_fullStr Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction
title_full_unstemmed Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction
title_sort impact of the clinical frailty scale on mid-term mortality in patients with st-elevated myocardial infarction
publisher Elsevier
series International Journal of Cardiology: Heart & Vasculature
issn 2352-9067
publishDate 2019-03-01
description Background: “Frailty” is associated with poor prognosis in ST-elevated myocardial infarction (STEMI). However, there is little data regarding the impact of the Canadian Study of Health and Aging Clinical Frailty Scale (CFS), a simple and semiquantitative tool for assessing frailty, on mid-term mortality in STEMI patients. Methods: A total of 354 consecutive STEMI patients (mean age 69.8 ± 12.4 years; male 76.6%) who underwent percutaneous intervention between July 2014 and March 2017 were retrospectively reviewed. The study endpoint was mid-term mortality according to the CFS classification. Furthermore, in order to clarify the impact of CFS upon admission on mid-term mortality, the independent predictors of all-cause death were evaluated. Results: Patients were categorized into three groups (CFS 1–3, n = 281; CFS 4–5, n = 62; and CFS 6–7, n = 11). During the study period (median 474 days), all-cause death was observed in 39 patients. After multivariate Cox regression analysis, higher CFS (adjusted hazard ratio [HR] 2.34, 95% confidence interval [CI] 1.43–3.85, p < 0.001), higher Killip score (adjusted HR 2.46, 95%CI 1.30–5.78, p = 0.002), and lower serum albumin level (adjusted HR 4.29, 95%CI 2.16–8.51, p < 0.001) were significantly associated with an increased risk of all-cause death. Conclusion: In conclusion, severe frailty was associated with mid-term mortality in STEMI patients who underwent PCI. Keywords: Coronary heart disease, ST-elevated myocardial infarction, Frail, Prognosis
url http://www.sciencedirect.com/science/article/pii/S235290671930003X
work_keys_str_mv AT naokiyoshioka impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT kensuketakagi impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT yasuhiromorita impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT rukayoshida impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT hiroakinagai impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT yasunorikanzaki impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT koichifurui impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT ryotayamauchi impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT shotarokomeyama impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT hirokisugiyama impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT hideyukitsuboi impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
AT itsuromorishima impactoftheclinicalfrailtyscaleonmidtermmortalityinpatientswithstelevatedmyocardialinfarction
_version_ 1725527634619662336